Siemens Total Bilirubin Reagent Cartridge Recall for Eltrombopag Interference
Siemens Healthcare is recalling Dimension Total Bilirubin Flex reagent cartridges because the assay may show falsely high results for patients taking eltrombopag.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard is a potential for inaccurate test results (positive bias) in a specific patient population (those on eltrombopag), which fits the criteria for moderate severity involving low-risk contamination or minor labeling/functional errors without reported serious injuries.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling Dimension Total Bilirubin Flex reagent cartridges (SMN: 10444957). The recall involves 1,639 units in the United States and 747 units in foreign markets. The product is an in vitro diagnostic test used to measure total bilirubin in human serum and plasma, which is used in the diagnosis and treatment of liver, hemolytic, hematological, and metabolic disorders.
The recall is being conducted because bilirubin assays using these cartridges may exhibit a positive bias in patients who are on eltrombopag therapy. This means the test results may be falsely elevated for these specific patients. The affected lots were distributed nationwide in the US and to numerous foreign countries including those in Europe, Asia, Africa, and the Americas.
Healthcare facilities and laboratories should stop using the affected lots of the Dimension Total Bilirubin Flex reagent cartridge. Siemens Healthcare Diagnostics, Inc. is the recalling firm. Users should contact the manufacturer for further instructions on how to manage the recall and replace the affected units.
The recalled product
- Product
- Dimension Total Bilirubin Flex reagent cartridge -In vitro Diagnostic for the determination of total bilirubin. SMN: 10444957 Product Usage: Dimension TBI method for the ¿ clinical chemistry syst6em is an in vitro diagnostic test intended to quantitatively measure total bi
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Hazard
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · inaccurate test result
See all →- ModerateTosoh ST AIA-Pack Testosterone Diagnostic Test Kit Recall
FDA (Devices) · 2026-07-22
- ModerateAbbott HbA1c Hemoglobin Afinion Test Kit Cold Chain Failure
FDA (Devices) · 2025-06-04
- HighFDA Recalls Multiple Unauthorized Diagnostic Test Products by Universal Meditech
FDA (Devices) · 2023-11-01
- HighSTA R Max Analyzer Firmware Bug Produces Inaccurate Coagulation Test Results
FDA (Devices) · 2023-05-17
- HighRoche CoaguChek XS Prothrombin Time Test Strips Recalled for High INR Results
FDA (Devices) · 2018-11-14